2025
LITA: An Efficient LLM-Assisted Iterative Topic Augmentation Framework
Chang C, Tsai J, Tsai Y, Hwang S. LITA: An Efficient LLM-Assisted Iterative Topic Augmentation Framework. Lecture Notes In Computer Science 2025, 15870: 449-460. DOI: 10.1007/978-981-96-8170-9_35.Peer-Reviewed Original ResearchAugmentation frameworkClustering performance metricsText clusteringTopic qualityLanguage modelSeed wordsTopic modelsText corpusPerformance metricsBaseline modelIterative refinementAPIGuided approachLabor-intensiveFrameworkTraditional modelsThematic structureTextDatasetMetricsLDAIterationClustersCostModelPaging and the Address-Translation Problem
Bender M, Bhattacharjee A, Conway A, Farach-Colton M, Johnson R, Kannan S, Kuszmaul W, Mukherjee N, Porter D, Tagliavini G, Vorobyeva J, West E. Paging and the Address-Translation Problem. ACM Transactions On Algorithms 2025 DOI: 10.1145/3737700.Peer-Reviewed Original ResearchPublic transport pricing: An evaluation of the 9-Euro ticket and an alternative policy proposal
Andor M, Dehos F, Gillingham K, Hansteen S, Tomberg L. Public transport pricing: An evaluation of the 9-Euro ticket and an alternative policy proposal. Economics Of Transportation 2025, 42: 100415. DOI: 10.1016/j.ecotra.2025.100415.Peer-Reviewed Original ResearchPublic transportIntroduction of dynamic pricingCar tripsHigher welfare gainsDynamic pricingAlternative policy proposalsWelfare effectsWelfare gainsEconomic theoryAlternative policiesPublic fundsPolicy proposalsPotential policiesEmpirical approachTransportPolicyTripsPriceCarEuroFundingWelfareCostEvidence
2024
Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under Uncertainty
Yaesoubi R, Kunst N. Net Monetary Benefit Lines Augmented with Value-of-Information Measures to Present the Results of Economic Evaluations under Uncertainty. Medical Decision Making 2024, 44: 770-786. PMID: 39056310, PMCID: PMC12181631, DOI: 10.1177/0272989x241262343.Peer-Reviewed Original ResearchResults of cost-effectiveness analysesNet monetary benefitCost-effectiveness planeCost-effectiveness analysisMonetary benefitsDecision uncertaintyDecision problemEffect estimatesHypothetical decision problemResults of economic evaluationsValue-of-informationDecision makersCost-effectiveness ratioEconomic evaluation studiesCorrelated costsHigh varianceLevel of uncertaintyParameter uncertaintiesEconomic evaluationMagnitude of parametersMakersDecisionUncertaintyCostMonetaryComb EMI: a hardware-free, training-free approach to EMI correction
Sun H, Sun C, Ha Y, Samardzija A, Gross R, Galiana G, Constable R. Comb EMI: a hardware-free, training-free approach to EMI correction. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2024 DOI: 10.58530/2024/2691.Peer-Reviewed Original ResearchElectromagnetic interferenceTraining-freeNoise-dominated regionTraining dataDesign complexityExternal hardwareHardware-freeExtra hardwareHardwareDesign possibilitiesPoint-of-careExperimental dataMRI systemWhite noiseCancellationImprove costSparsitySampling windowSNRDesignTrainingPassive shieldingPortabilityCostMethodThe Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret Shopping
Blough M, Rocha A, Bratberg J, Silcox J, Bolivar D, Floyd A, Gray M, Green T. The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret Shopping. Substance Abuse 2024, 45: 201-210. PMID: 38258818, DOI: 10.1177/29767342231217831.Peer-Reviewed Original Research
2023
Field Experimental Evidence on the Effect of Pricing on Residential Electricity Conservation
Burkhardt J, Gillingham K, Kopalle P. Field Experimental Evidence on the Effect of Pricing on Residential Electricity Conservation. Management Science 2023, 69: 7784-7798. DOI: 10.1287/mnsc.2020.02074.Peer-Reviewed Original ResearchEmission reductionField experimental evidenceGreenhouse gas emission reductionEffect of priceGas emission reductionWarm glowElectricity conservationMonetary incentivesEffort costsOnline appendixElectricity consumptionConsumer tradeoffsTexas householdsResidential consumersPriceElectric utilitiesAppliance-level dataGeneration costConsumersOff-peakLoad shiftingElectricityClimate changeIncentivesCostGlobal, regional, and country-level cost of leptospirosis due to loss of productivity in humans
Agampodi S, Gunarathna S, Lee J, Excler J. Global, regional, and country-level cost of leptospirosis due to loss of productivity in humans. PLOS Neglected Tropical Diseases 2023, 17: e0011291. PMID: 37616329, PMCID: PMC10482283, DOI: 10.1371/journal.pntd.0011291.Peer-Reviewed Original ResearchConceptsGross domestic productDisability-adjusted life yearsProductivity costsWorld Bank data repositoryLoss of productivityHealth expenditure dataEconomic burden estimatesHigher productivity costsDomestic productExpenditure dataInternational dollarsOverall economic burdenMonetary valueEconomic burdenAsia-Pacific regionIntangible costsLife yearsEconomic costsCost estimatesIncome countriesDiseases of povertyPartial estimatesCostProductivityCountriesValue Proposition of FDA-Approved Artificial Intelligence Algorithms for Neuroimaging
Bajaj S, Khunte M, Moily N, Payabvash S, Wintermark M, Gandhi D, Malhotra A. Value Proposition of FDA-Approved Artificial Intelligence Algorithms for Neuroimaging. Journal Of The American College Of Radiology 2023, 20: 1241-1249. PMID: 37574094, DOI: 10.1016/j.jacr.2023.06.034.Peer-Reviewed Original ResearchConceptsArtificial intelligence algorithmsAI algorithmsIntelligence algorithmsValue propositionUser timeAI developersMost vendorsProduct informationDevelopersAlgorithmVendorsProduct websitesDeveloper websitesWebsitesUser testimonialsCentral databaseTechnologyDatabaseInformationAIDevicesAdoptionPropositionCostCost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?
Bewersdorf J, Huntington S, Zeidan A. Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future? Journal Of The National Comprehensive Cancer Network 2023, 21: 522-528. PMID: 37037494, DOI: 10.6004/jnccn.2023.70012.Peer-Reviewed Original ResearchConceptsCost-effectiveness analysisEconomic modeling techniquesCost-effectiveness studiesFinite financial resourcesDrug pricesHealth policy decisionsPolicy decisionsFinancial resourcesResource allocationUnited StatesPublic interestCostHealthcare systemPricesSuch analysesLimited resourcesAllocationCountriesConsumersData sourcesPayersAssumptionBenefitsBudgetary considerationsDifferent interventionsEstimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
Chatterjee A, Weitz M, Savinkina A, Macmadu A, Madushani R, Potee R, Ryan D, Murphy S, Walley A, Linas B. Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts. JAMA Network Open 2023, 6: e237036. PMID: 37058306, PMCID: PMC10105308, DOI: 10.1001/jamanetworkopen.2023.7036.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioIncremental costCost-effectiveness ratioEconomic evaluationEconomic studiesOpioid use disorderXR-naltrexoneOverdose deathsTreatment startQALYOverdose mortalityUse disordersCostExtended-release naltrexoneTreatment costsDiscontinue medicationsMOUD accessQALYsOpen cohortMost prisonsIncarcerated individualsMOUD treatmentTreatment strategiesMoneyFatal overdosesTrends in Private Equity Acquisitions of US Otolaryngology Practices
Shah H, Salehi P, Torabi S, Bourdillon A, Wu K, Mehra S. Trends in Private Equity Acquisitions of US Otolaryngology Practices. Otolaryngology 2023, 169: 1094-1097. PMID: 37003295, DOI: 10.1002/ohn.342.Peer-Reviewed Original ResearchDSFormer: A Dual-domain Self-supervised Transformer for Accelerated Multi-contrast MRI Reconstruction
Zhou B, Dey N, Schlemper J, Salehi S, Liu C, Duncan J, Sofka M. DSFormer: A Dual-domain Self-supervised Transformer for Accelerated Multi-contrast MRI Reconstruction. 2023, 00: 4955-4964. DOI: 10.1109/wacv56688.2023.00494.Peer-Reviewed Original ResearchReconstruction networkSelf-supervised learning strategyHigh-fidelity reconstructionConvolutional architectureMRI reconstructionTraining dataFull supervisionInformation sharingTime costMulti-contrast MRINetworkLearning strategiesMultiple acquisitionsArchitectureSharingFine anatomical detailsRedundancyCostMultiple contrastsMRI sequencesReconstructionComplementary imaging modalities
2022
Rhytidectomy—Information Patients Seek and Where They Find Answers
Fritz C, Ravin E, Suresh N, Lowery A, Rajasekaran K. Rhytidectomy—Information Patients Seek and Where They Find Answers. Facial Plastic Surgery 2022, 39: 201-209. PMID: 36174657, DOI: 10.1055/a-1952-8569.Peer-Reviewed Original ResearchHow Far Is Too Far? Cost-Effectiveness Analysis of Regionalized Rectal Cancer Surgery
Leeds I, Xu Z, Loria A, Pantel H, Mongiu A, Longo W, Reddy V. How Far Is Too Far? Cost-Effectiveness Analysis of Regionalized Rectal Cancer Surgery. Diseases Of The Colon & Rectum 2022, 66: 467-476. PMID: 36538713, DOI: 10.1097/dcr.0000000000002636.Peer-Reviewed Original ResearchConceptsMultivariable probabilistic sensitivity analysesCost-effectiveness standardsIncremental cost-effectiveness ratioProbabilistic sensitivity analysesCost-effectiveness analysisCost-effectiveness ratioTotal societal costsSensitivity analysisDecision analysis modelEl análisisSocietal perspectiveIncremental costPacientes con cáncerSocietal costsLos costosLargo plazoPolicy levelDecision analysisTotal costCostPopulation-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis
Savinkina A, Paltiel A, Ross J, Gonsalves G. Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing—A Cost-effectiveness Analysis. Open Forum Infectious Diseases 2022, 9: ofac637. PMID: 36589482, PMCID: PMC9792084, DOI: 10.1093/ofid/ofac637.Peer-Reviewed Original ResearchCost-effectiveness analysisTrade-offs implicitSevere diseaseDecision analytic modelAllocation decisionsPay thresholdsPolicy strategiesUnvaccinated patientsVaccination statusHigh riskTreatment effectivenessHigh-risk individualsAllocation strategyPopulation-level strategiesWillingnessFurther priorityDrug costsSensitivity analysisCostRitonavir treatmentUnvaccinated personsVaccinated adultsPatient populationClinical trialsLower riskCost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic core
Sanmartin M, Katz J, Wang J, Malhotra A, Sangha K, Bastani M, Martinez G, Sanelli P. Cost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic core. Journal Of NeuroInterventional Surgery 2022, 15: e166-e171. PMID: 36175016, DOI: 10.1136/jnis-2022-019460.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsIncremental cost-effectiveness ratioNet monetary benefitProbabilistic sensitivity analysesEconomic evaluation studiesCost-effectiveness analysisCost-effectiveness ratioSensitivity analysisTwo-way sensitivity analysesLifetime healthcare costsMonetary benefitsLife yearsLifetime costsLifetime benefitsLarge ischemic coreStandard careCost-effective strategyEVTIschemic coreStroke patientsAIS patientsPatient's lifetimeAcute ischemic stroke patientsCostEndovascular thrombectomy treatmentEstimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study
Savinkina A, Bilinski A, Fitzpatrick M, Paltiel AD, Rizvi Z, Salomon J, Thornhill T, Gonsalves G. Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study. BMJ Open 2022, 12: e061752. PMID: 36100306, PMCID: PMC9471205, DOI: 10.1136/bmjopen-2022-061752.Peer-Reviewed Original ResearchConceptsLow-income countriesIncome countriesDeath avertedHigh-income nationsStatistical lifeAvertable deathsIncome nationsCOVID-19 deathsReasonable investmentHigh costKey inputCountriesParameter estimatesAvertedCostSensitivity analysisUniversal vaccinationGlobal vaccinationMRNA COVID-19 vaccinationNationsInvestmentPrimary vaccine seriesLow vaccine effectivenessCOVID-19 vaccinationPublic dataThe order flow cost of index rolling in commodity futures markets
Irwin S, Sanders D, Yan L. The order flow cost of index rolling in commodity futures markets. Applied Economic Perspectives And Policy 2022, 45: 1025-1050. DOI: 10.1002/aepp.13297.Peer-Reviewed Original ResearchCost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke
Zhou LW, Kraler L, de Havenon A, Lansberg MG. Cost‐Effectiveness of Cilostazol Added to Aspirin or Clopidogrel for Secondary Prevention After Noncardioembolic Stroke. Journal Of The American Heart Association 2022, 11: e024992. PMID: 35656996, PMCID: PMC9238703, DOI: 10.1161/jaha.121.024992.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsHealth care costsHigher quality-adjusted life yearsNet monetary benefitLifetime quality-adjusted life yearsProbabilistic sensitivity analysesCare costsMonetary benefitsSensitivity analysisLife yearsCost inputsLifetime costsLower health care costsCost savingsCostBest available dataWillingnessSavingsMonte Carlo simulationsTreatment effectsCarlo simulationsAvailable dataBenefitsDecision tree
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply